US-based biomedical technology company SetPoint Medical Corporation has raised $30m in a Series D financing round led by New Enterprise Associates.
The company plans to use the funds to advance the development of its bioelectronic therapy for inflammatory diseases.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Chinese company Zhuhai Hokai Medical Instruments Co Ltd plans to raise CNY1bn ($150.1m) through the public offering of convertible bonds due in 2023.
US-based genomics research and diagnostics company MedGenome Inc has secured $30m in a Series C venture financing round led by Sequoia Capital India Advisors Pvt Ltd.
The company intends to use the stocks to progress its biomarker discovery programmes.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
